60 Degrees Pharmaceuticals, Inc. (SXTP)

Balance Sheet (Annual)

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020
Cash & Equivalents	0.26	0.12	0.2
Cash & Cash Equivalents	0.26	0.12	0.2
Cash Growth	129.52%	-42.66%	-
Receivables	0.05	0.15	0.86
Inventory	0.52	0.69	1.04
Other Current Assets	0.27	0.23	0.34
Total Current Assets	1.1	1.18	2.44
Property, Plant & Equipment	0.03	0.11	0.07
Goodwill and Intangibles	0.16	0.11	0.08
Other Long-Term Assets	0	0	0.01
Total Long-Term Assets	0.2	0.22	0.16
Total Assets	1.3	1.39	2.61
Accounts Payable	0.76	0.59	1.38
Current Debt	21.34	0.05	0
Other Current Liabilities	1.82	0	0.06
Total Current Liabilities	23.92	0.64	1.43
Long-Term Debt	1.27	18.76	19.14
Other Long-Term Liabilities	0.26	0.15	0.1
Total Long-Term Liabilities	1.53	18.91	19.24
Total Liabilities	25.45	19.55	20.68
Total Debt	22.61	18.8	19.14
Debt Growth	20.25%	-1.76%	-
Common Stock	5.16	4.98	0.8
Retained Earnings	-28.82	-22.63	-18.38
Comprehensive Income	0.07	0.08	0.08
Shareholders' Equity	-23.58	-17.58	-17.5
Net Cash / Debt	-22.35	-18.69	-18.94
Net Cash Per Share	-9.39	-	-
Working Capital	-22.82	0.54	1.01
Book Value Per Share	-9.90	-7.37	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).